文献速递血管炎

川崎病中的阿司匹林剂量:持续存在的争议

Aspirin Dose in Kawasaki Disease: The Ongoing Battle.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-09-07

该研究回顾性比较加拿大2个中心川崎病患者的两种阿司匹林剂量方案,低剂量组(3-5 mg/kg/天)需第二次静脉注射免疫球蛋白(IVIG)的比例为23%(28/122),高剂量组(80-100 mg/kg/天)为8.7%(11/127),校正混杂因素后低剂量阿司匹林与更高的IVIG耐药风险相关(OR 3.2 [95%CI 1.1, 9.1])。两组住院时长和冠状动脉瘤发生率无显著差异。

要点

  • 低剂量阿司匹林组IVIG再治疗率为23%(28/122),高剂量组为8.7%(11/127),P=0.003。
  • 校正混杂因素后,低剂量阿司匹林与更高的IVIG耐药风险相关(OR 3.2 [95%CI 1.1, 9.1])。
  • 两组住院时长和冠状动脉瘤发生率无显著差异。

核心结论

  • 与高剂量阿司匹林相比,低剂量阿司匹林与约3倍的IVIG再治疗风险相关,住院时长和冠状动脉瘤发生率无显著差异。

研究设计与样本

  • 回顾性研究,审查加拿大2个中心川崎病患者的病历,比较阿司匹林剂量对IVIG耐药(操作定义为给予第二剂IVIG)的影响。
  • 两中心均使用标准IVIG给药方案,中心1从诊断起使用低剂量阿司匹林(3-5 mg/kg/天),中心2使用初始高剂量阿司匹林(80-100 mg/kg/天)。

主要发现

  • 两中心基线特征无显著差异。
  • 低剂量阿司匹林组122例中28例(23%)需要第二剂IVIG再治疗,高剂量阿司匹林组127例中11例(8.7%)需要再治疗(P = 0.003)。
  • 校正混杂因素后,低剂量阿司匹林与更高的IVIG耐药风险相关(OR 3.2 [95%CI 1.1, 9.1])。
  • 平均住院时长分别为4.1天和4.7天(P = 0.37)。
  • 冠状动脉瘤在中心1的117例中见2例,中心2的125例中见6例(P = 0.28)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Kawasaki disease (KD) is an acute childhood vasculitis that may result in coronary aneurysms. Treatment of KD with a single infusion of 2 gm/kg intravenous immunoglobulin (IVIG) is well established, but acetylsalicylic acid (ASA) dose remains controversial. Our primary objective was to determine the difference in the incidence of IVIG resistance between 2 ASA doses. Our secondary objective was to compare the duration of hospital stay and the incidence of coronary artery aneurysm. METHODS: We reviewed charts of patients with KD from 2 Canadian centers to assess the impact of ASA dose on IVIG resistance (operationally defined as administration of a second dose of IVIG). Both centers used standard IVIG dosing, but center 1 used low-dose ASA from diagnosis (3-5 mg/kg/day) while center 2 used initial high-dose ASA (80-100 mg/kg/day). RESULTS: There were no significant differences in baseline characteristics between the 2 centers. Retreatment with a second dose of IVIG was required in 28 of 122 patients (23%) treated with low-dose ASA, and in 11 of 127 patients (8.7%) treated with high-dose ASA in center 1 and center 2, respectively (P = 0.003). After adjusting for confounders, low-dose ASA was associated with higher odds of IVIG resistance (OR 3.2 [95% confidence interval 1.1, 9.1]). The mean duration of hospital stay was 4.1 and 4.7 days, respectively (P = 0.37). Coronary artery aneurysms were seen in 2 of 117 and 6 of 125 patients from centers 1 and 2, respectively (P = 0.28). CONCLUSION: Low-dose ASA was associated with 3-times higher odds of IVIG retreatment compared to high-dose ASA, with no significant difference in duration of hospital stay or incidence of coronary artery aneurysms.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Dhanrajani A, Chan M, Pau S, et al. Aspirin Dose in Kawasaki Disease: The Ongoing Battle. Arthritis Care Res (Hoboken). 2018. PMID: 29287309. doi:10.1002/acr.23504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。